BI
Biocept, Inc.
BIOCQ · OTC
$0.00 +0.00% (+$0.00)
1M +19,900.00%
Market Cap $525.0
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
78 /100
Growing Rev. growth 67.24%
Book val. growth 7.52%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 9.99%
FCF margin 54.51%
Net margin 124.09%
Quality
15 /100
Poor ROIC 117.56%
Asset turnover 0.84x
ROA 103.93%
Debt
62 /100
Moderate Debt/Equity 1.37x
Net debt/EBITDA 0.03x
Current ratio 2.97x
Stability
1 /100
Unstable Beta 3.98x
Profitable years 0
Rev. volatility 228.82%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BIOCQ
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Soon Kap Hahn
Employees
50
Headquarters
San Diego
Upcoming events
24 NOV
Earnings
Upcoming earnings report